Q2 FY25 Quarterly Investor Presentation & Webinar
Filed with ASX · · 40 pages · English
Watch Microba Life Sciences' latest callMicroba Life Sciences (ASX:MAP) Q4 2025 Earnings Call · Replay · Jul 22, 2025Read the transcript of Microba Life Sciences (ASX:MAP) Q4 2025 Earnings CallPresenting: CEO, Dr Luke Reid Webinar Access: The Quarterly Investor Presentation Video can now be accessed on demand via Microba’s Investor Hub at the following link Q2 FY25 Quarterly Investor Webinar Investor Q&As We invite investors and interested parties to submit questions on the Quarterly Investor Presentation & Webinar through the ‘Ask a question’ section of Microba’s interactive investor p
Microba Life Sciences Limited on 6ix
In the deck
Story so far
Earlier from Microba Life Sciences
- Q2 FY25 Quarterly Activities Report & Appendix 4C
- Trading Update
- Microba receives $6 million R&D Tax Incentive Refund
- Q1 FY25 Quarterly Investor Presentation
- Q1 FY25 Quarterly Activities Report & Appendix 4C
Later from Microba Life Sciences
- Appendix 4D & FY25 Interim Report
- Microba Delivers Landmark IBD Results & Signs Major Gastro Partner
- Q3 FY25 Quarterly Activities Report & Appendix 4C
- Q3 FY25 Quarterly Investor Presentation & Webinar
- Landmark GI Study Results from over 4,600 patients
Follow Microba Life Sciences into a list and get an email when it puts out news.
Follow Microba Life Sciences